Literature DB >> 21848520

Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia.

Tim Ripperger1, Marcel Tauscher, Inka Praulich, Brigitte Pabst, Andrea Teigler-Schlegel, Allen Yeoh, Gudrun Göhring, Brigitte Schlegelberger, Christian Flotho, Charlotte M Niemeyer, Doris Steinemann.   

Abstract

Juvenile myelomonocytic leukaemia (JMML) is a unique myeloproliferative disorder of early childhood. Frequently, mutations in NRAS, KRAS, PTPN11, NF1 or CBL are found in these patients. Monosomy 7 is the most common cytogenetic aberration. To identify submicroscopic genomic copy number alterations, 20 JMML samples were analysed by comparative genomic hybridization. Ten out of 20 samples displayed additional submicroscopic alterations. In two patients, an almost identical gain of chromosome 8 was identified. In both patients, fluorescence in situ hybridization confirmed a constitutional partial trisomy 8 mosaic (cT8M). A survey on 27 cT8M patients with neoplasms showed that 21 had myeloid malignancies, and five of these had a JMML. Notably, the region gained in our cases is the smallest gain of chromosome 8 reported in cT8M cases with malignancies so far. Our results dramatically reduce the critical region to 8p11.21q11.21 harbouring 31 protein coding genes and two non-coding RNAs, e.g. MYST3, IKBKB, UBE2V2, GOLGA7, FNTA and MIR486--a finding with potential implications for the role of somatic trisomy 8 in myeloid malignancies. Further investigations are required to more comprehensively determine how constitutional partial trisomy 8 mosaicisms may contribute to leukaemogenesis in different mutational subtypes of JMML and other myeloid malignancies.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21848520     DOI: 10.1111/j.1365-2141.2011.08817.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

Review 1.  The pur protein family: genetic and structural features in development and disease.

Authors:  Edward M Johnson; Dianne C Daniel; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2013-05       Impact factor: 6.384

Review 2.  Pediatric Neoplasms Presenting with Monocytosis.

Authors:  Jacob R Greenmyer; Mira Kohorst
Journal:  Curr Hematol Malig Rep       Date:  2021-02-25       Impact factor: 3.952

3.  Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?

Authors:  Sílvia Saumell; Francesc Solé; Leonor Arenillas; Julia Montoro; David Valcárcel; Carme Pedro; Carmen Sanzo; Elisa Luño; Teresa Giménez; Montserrat Arnan; Helena Pomares; Raquel De Paz; Beatriz Arrizabalaga; Andrés Jerez; Ana B Martínez; Judith Sánchez-Castro; Juan D Rodríguez-Gambarte; José M Raya; Eduardo Ríos; María Rodríguez-Rivera; Blanca Espinet; Lourdes Florensa
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

4.  Acute Myeloid Leukemia With RBM15-MKL1 Presenting as Severe Hepatic Failure.

Authors:  Yoshiko Nakano; Kai Yamasaki; Yasunori Otsuka; Atsushi Ujiro; Rie Kawakita; Nobuyoshi Tamagawa; Keiko Okada; Hiroyuki Fujisaki; Tohru Yorifuji; Junichi Hara
Journal:  Glob Pediatr Health       Date:  2017-01-24

Review 5.  Paediatric Behçet's Disease: A Comprehensive Review with an Emphasis on Monogenic Mimics.

Authors:  Ovgu Kul Cinar; Micol Romano; Ferhat Guzel; Paul A Brogan; Erkan Demirkaya
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

Review 6.  MiRNA Dysregulation in Childhood Hematological Cancer.

Authors:  Jaqueline Carvalho de Oliveira; Gabriela Molinari Roberto; Mirella Baroni; Karina Bezerra Salomão; Julia Alejandra Pezuk; María Sol Brassesco
Journal:  Int J Mol Sci       Date:  2018-09-10       Impact factor: 5.923

Review 7.  Understanding Behçet's Disease in the Context of Innate Immunity Activation.

Authors:  Sandro F Perazzio; Luis E C Andrade; Alexandre W S de Souza
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.